Excellence in Oncology Care (EIOC) shared a post on LinkedIn:
“We are honored to welcome back Professor Tobias Arkenau (UK) to the Excellence in Oncology Care (EIOC) Congress!
A distinguished medical oncologist, Prof. Arkenau is internationally recognized for his expertise in gastrointestinal cancers and immunotherapies. With a remarkable career spanning clinical practice, drug development, and research leadership, he has served as Executive Medical Director at Sarah Cannon Research Institute UK and now holds the role of CMO and Global Head of Drug Development at Ellipses Pharma.
Join him at the Immuno-Oncology Session, where he will share valuable insights shaped by years of pioneering work in cancer research and clinical trials.
Register now.”
More posts featuring EIOC on OncoDaily.